From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
The latest installment of our Launch Readiness webinar series focuses on mission-critical activities for life sciences companies approaching commercial launch. We continue the webinar series with a comprehensive countdown of the key gross-to-net (GTN) milestones your team needs to achieve as you prepare for launch.
During the webinar we discuss essential line items on the GTN roadmap such as deadlines for enrollment in government programs and product pricing decisions. We’ll share specific insights from companies like yours to highlight different approaches to the most complex GTN activities such as:
Presenter: Jennifer Sharpe, Executive Advisor, Revenue Analytics Collaborative We also share benchmarks via the Revenue Analytics Collaborative and discuss best practices related to the development of forecasting and accrual management models. This section of the presentation will include a customer case study on the successful transition from Excel-based GTN accrual forecasting and modeling to GTN automation within one year of launch.
